Transfusion and Apheresis Science

Papers
(The TQCC of Transfusion and Apheresis Science is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Anemia is associated with severe coronavirus disease 2019 (COVID-19) infection65
Inventory management in blood supply chain considering fuzzy supply/demand uncertainties and lateral transshipment54
CRISPR/Cas9 gene editing for curing sickle cell disease46
Relapse of thrombotic thrombocytopenic purpura after COVID-19 vaccine36
Potential of therapeutic plasmapheresis in treatment of COVID-19 patients: Immunopathogenesis and coagulopathy32
Convalescent plasma therapy in patients with COVID-1931
Systematic review and meta-analysis of the susceptibility of ABO blood group to COVID-19 infection29
Promoting access to COVID-19 convalescent plasma in low- and middle-income countries27
SARS-CoV-2 serology and virology trends in donors and recipients of convalescent plasma25
SARS-CoV-2 convalescent plasma therapy in pediatric patient after hematopoietic stem cell transplantation25
Seroprevalence of SARS-CoV-2 antibodies among healthy blood donors in Karachi, Pakistan22
Convalescent plasma therapy for severe Covid-19 in patients with hematological malignancies22
Role of therapeutic plasma exchange in the management of COVID-19-induced cytokine storm syndrome21
No transmission of SARS-CoV-2 in a patient undergoing allogeneic hematopoietic cell transplantation from a matched-related donor with unknown COVID-1920
Two patients with rituximab associated low gammaglobulin levels and relapsed covid-19 infections treated with convalescent plasma18
The use of convalescent plasma for pediatric patients with SARS-CoV-2: A systematic literature review18
Blood shortages and changes to massive transfusion protocols: Survey of hospital practices during the COVID-19 pandemic18
Symmetrical peripheral gangrene in critical illness18
Emerging insights into the role of albumin with plasma exchange in Alzheimer’s disease management15
Therapeutic plasma exchange (TPE) as a plausible rescue therapy in severe vaccine-induced immune thrombotic thrombocytopenia15
Analysis of blood donors’ characteristics and deferrals related to COVID-19 in Iran13
Therapeutic plasma exchange: A potential management strategy for critically ill MIS-C patients in the pediatric intensive care unit13
Convalescent plasma to aid in recovery of COVID-19 pneumonia in a child with acute lymphoblastic leukemia13
COVID-19: Further evidence of no transfusion transmission12
Role of the AB0 blood group in COVID-19 infection and complications: A population-based study12
Wound healing effect of autologous fibrin glue and polyglycolic acid sheets in a rat back skin defect model12
Successful management of three patients with autoimmune thrombotic thrombocytopenic purpura with paradigm-changing therapy: Caplacizumab, steroids, plasma exchange, rituximab, and intravenous immunogl12
COVID-19 neutralizing antibody-based therapies in humoral immune deficiencies: A narrative review12
Convalescent plasma therapy in patients with COVID-1912
People with blood disorders can be more vulnerable during COVID-19 pandemic: A hypothesis paper11
Therapeutic plasma exchange and continuous renal replacement therapy in pediatric dengue-associated acute liver failure: A case series from Vietnam11
Artificial intelligence meets hematology11
SARS-CoV-2 antibody changes in patients receiving COVID-19 convalescent plasma from normal and vaccinated donors11
Autoimmune complications of COVID-19 and potential consequences for long-lasting disease syndromes11
Assessment of serum iron stores in regular plateletpheresis donors10
Cellular therapy for the treatment of solid tumors10
Platelet and extracellular vesicles in COVID-19 infection and its vaccines10
Motivators, barriers and communication channels for blood donation in relation to students at a university in Spain10
Leukoreduction makes a difference: A pair proteomics study of extracellular vesicles in red blood cell units10
Peripheral Blood Stem Cell Mobilization and Collection in Pediatric Healthy Sibling Donors Weighing 20 Kilograms or Less; Algerian Experience10
Lessons learned from the use of convalescent plasma for the treatment of COVID-19 and specific considerations for immunocompromised patients9
Non-fungible tokens: Stem cell transplantation in the blockchain9
Mesenchymal stromal cells: Getting ready for clinical primetime9
Understanding the demand for phenotyped red blood cell units and requests to perform molecular red blood cell typing for Australian patients9
Effects of cell concentration, time of fresh storage, and cryopreservation on peripheral blood stem cells9
Is pathogen reduction an acceptable alternative to irradiation for risk mitigation of transfusion-associated graft versus host disease?9
The effect of therapeutic plasma exchange on management of HELLP Syndrome: The report of 47 patients9
A look-back at convalescent plasma to treat COVID-199
Optimizing pediatric peripheral blood stem cell collection9
Baseline haemoglobin and thromboelastometry are predictive of red blood cell requirements and one-year mortality in liver transplantation9
Addition of plerixafor to G-CSF in poor mobilizing healthy related donors overcame mobilization failure: An observational case series on behalf of the Grupo Español de Trasplante Hematopoyético (GETH)8
Therapeutic plasma exchange in critically ill children: experience of the pediatric intensive care unit of two centers in Chile8
Sickle cell disease in the new era: advances in drug treatment8
Labile iron, ROS, and cell death are prominently induced by haemin, but not by non-transferrin-bound iron8
Effectiveness of supplemental oral calcium drink in preventing citrate-related adverse effects in peripheral blood progenitor cell collection8
Spotlight on animal models of acute traumatic coagulopathy: an update8
The impact of blood campaigns using mobile blood collection drives on blood supply management during the COVID-19 pandemic8
Mini-review on the properties and possible applications of therapeutic oxygen carrier Hemarina-M1018
Emerging use of machine learning and advanced technologies to assess red cell quality7
The successful management of an elderly Covid-19 infected patient by plasmapheresis7
Clinical and molecular characterization of Iranian patients with congenital fibrinogen disorders7
Blood donation and heavy metal poisoning in developing nations: Any link?7
Attenuation of age-elevated blood factors by repositioning plasmapheresis: A novel perspective and approach7
Novel autologous, high concentrated fibrin as advanced hemostatic agent for coronary surgery7
Analysis of extracorporeal photopheresis within the frame of the WAA register7
Immunotherapy for COVID-19: Evolving treatment of viral infection and associated adverse immunological reactions7
Complete neurological recovery from fat embolism syndrome in sickle cell disease after sequential red cell exchange transfusion and therapeutic plasma exchange7
Apoptosis as an underlying mechanism in lymphocytes induced by riboflavin and ultraviolet light7
N-acetylcysteine reduce the stress induced by cold storage of platelets: A potential way to extend shelf life of platelets7
Seroprevalence of SARS-Coronavirus 2 among asymptomatic healthy blood donors from healthcare and non-healthcare settings: Implications for safety of blood donors and blood collection staff during bloo7
Comparison of low fixed dose versus standard-dose rituximab to treat thrombotic thrombocytopenic purpura in the acute phase and preemptively during remission7
Acquired hemophilia A following COVID-19 vaccination – The importance of prompt diagnosis: A case report7
Awareness about Coronavirus (COVID-19) and challenges for blood services among potential blood donors7
Cargo-laden erythrocyte ghosts target liver mediated by macrophages7
Plasma exchange followed by convalescent plasma transfusion in COVID-19 patients7
Characteristics and causes of pre-donation deferrals at a Chinese blood center7
ROTEM in the setting of liver transplant surgery reduces frozen plasma transfusion7
Early high-titer convalescent plasma therapy in patients with moderate and severe COVID-196
Sero-prevalence of SARS-CoV-2 antibodies in blood donors during the third wave of infection in Norway, winter/spring 20216
Remodelling whole blood processing through automation and pathogen reduction technology at the Luxembourg Red Cross6
Role of therapeutic plasma exchanges in systemic vasculitis6
SARS-CoV-2 and cancer: the intriguing and informative cross-talk6
Gene therapy for hemoglobinopathies6
Patient blood management and blood conservation – Complimentary concepts and solutions for blood establishments and clinical services in South Africa and beyond6
Preparedness and activities of the anti-SARS-CoV-2 convalescent plasma bank in the Veneto region (Italy): An organizational model for future emergencies6
Intravenous Immunoglobulin and Favipiravir treatment for A Kidney Transplant Patient with Severe Covid-19 Pneumonia6
Transfusion Camp: Successes and challenges in scaling and expanding a transfusion medicine education program6
Platelet-rich plasma for the treatment of burn wounds: A meta-analysis of randomized controlled trials6
Acquired methemoglobinemia: A systematic review of reported cases6
An introductory commentary on the use of artificial intelligence, machine learning and TQM, as novel computational tools in big data patterns or procedural analysis, in transfusion medicine6
Leukapheresis for CAR-T cell production and therapy6
Analysis of ABO grouping discrepancies among patients from a tertiary hospital in Korea6
Blood donor deferral periods after COVID-19 vaccination6
Early therapeutic plasma exchange may improve treatment outcomes in severe acute toxic Hepatitis5
Taking therapeutic apheresis services to patients in South Africa: An eight year review of SANBS mobile therapeutic apheresis service, 2013–20205
Transient elastography of liver: Could it be a guide for diagnosis and management strategy in hepatic veno-occlusive disease (sinusoidal obstruction syndrome)?5
The association of ABO blood group with the asymptomatic COVID-19 cases in India5
Hepatitis-associated aplastic anemia in pediatric patients: single center experience5
Donor safety in an individualized plasmapheresis program – Results of an interim analysis5
Successful autologous peripheral blood stem cell collection using large volume leukapheresis in patients with very low or undetectable peripheral blood CD34+ progenitor cells5
COVID-19 antibody donation using immunoadsorption: Report of two cases5
Comparative evaluation of ADVIA Centaur® XP chemiluminescence system for screening of HBV, HCV, HIV and syphilis in Indian blood donors5
Analyses of registry data of patients with anti-GBM and antineutrophil cytoplasmatic antibody-associated (ANCA) vasculitis treated with or without therapeutic apheresis5
Iatrogenic anaemia and transfusion thresholds in ICU patients with COVID-19 disease at a tertiary care hospital5
Trends of Infectious Disease Markers Among Healthy Blood Donors In Northern India: A Ten Year Study5
Convalescent plasma therapy in B-cell-depleted and B-cell sufficient patients with life-threatening COVID-19 – A case series5
Double filtration plasmapheresis – 10-year pediatric experience as an alternative to plasma exchange5
Platelet supernatant with longer storage inhibits tumor cell growth5
Transfusion practices during the COVID-19 pandemic: An experience from a hematology daycare in India5
Secondary alloanti-D immunization post transfusion of “Asia type” DEL red blood cells5
COVID 19 convalescent plasma: Is there still a place for CCP?5
The importance of microbiota in hematology5
SARS-CoV-2 variants inactivation of plasma units using a riboflavin and ultraviolet light-based photochemical treatment5
Effects of ultrasound guided leukocyte-rich platelet-rich plasma (LR-PRP) injection in patients with pes anserinus tendinobursitis5
Therapeutic plasma exchange in pediatric patients with acute demyelinating syndromes of the central nervous system: A single-center experience5
Medical student education in transfusion medicine, part II: Moving forward to building up a "Know How" education program in transfusion medicine for under-graduate medical students5
Extracorporeal photopheresis in the treatment of acute graft-versus-host disease: A multicenter experience5
Bone marrow CD34 positive cells may be suitable for collection after death5
Screening for antibodies to HLA class I in apheresis donors following Covid‐19 or SARS-CoV-2 vaccination5
Usefulness of hematopoietic progenitor cell monitoring to predict autologous peripheral blood stem cell harvest timing: A single-center retrospective study5
Metabolomics comparison of cord and peripheral blood-derived serum eye drops for the treatment of dry eye disease5
The D-dimer reference intervals in healty term newborns5
Molecular identification of the emerging Human Gemykibivirus-2 (HuGkV-2) among Brazilian blood donors5
Plasma exchange and thrombotic microangiopathies: From pathophysiology to clinical practice5
Convalescent plasma as a treatment modality for coronavirus disease 2019 in Sudan5
Whole blood derived covid convalescent plasma: A practical experience from India5
Parameters affecting successful stem cell collections for genetic therapies in sickle cell disease4
Expression of biofilm-associated genes in Staphylococcus aureus during storage of platelet concentrates4
PD-1 blockader-associated atypical hemophagocytic lymphohistiocytosis: A cautionary case report4
COVID-19-associated Evans syndrome: A case report and review of the literature4
Plerixafor combined with G-CSF for stem cell mobilization in children qualified for autologous transplantation- single center experience4
Efficacy of therapeutic plasma exchange in pediatric cases of acute liver failure as an extracorporeal liver support system4
Frequency and specificity of Red blood cell alloantibodies in multitransfused Egyptian patients with hematological and nonhematological malignancies4
Is it necessary to add the eluate testing to the direct antiglobulin test to improve the detection of maternal erythrocyte alloantibodies?4
Benford’s law and metabolomics: A tale of numbers and blood4
Use of granulocyte transfusion in early period in life-threatening infections of pediatric hematology and oncology patients: A single-center experience4
Blood supply management during the Covid-19 pandemic: Experience in a tertiary referral hospital in Malaysia4
Changes in blood donation and utilization secondary to Covid-19 outbreak4
SARS CoV 2 infection in chronic myelogenous leukemia: Severe hematological presentation4
Real-world data of the use and experience of caplacizumab for the treatment of acquired thrombotic thrombocytopenic purpura: Case series4
Utilization of emicizumab in acquired hemophilia A: A case report4
Non-crisis related pain occurs in adult patients with sickle cell disease despite chronic red blood cell exchange transfusion therapy4
Complete ADAMTS13 remission in a patient with refractory autoimmune-mediated thrombotic thrombocytopenic purpura after infliximab4
Retrospective analysis of direct antiglobulin test positivity at tertiary academic hospital over 10 years4
Thrombocytopenia due to rivaroxaban: A rare adverse effect4
Basic principles of therapeutic plasma exchange4
Investigating the production of platelet lysate obtained from low volume Cord Blood Units: Focus on growth factor content and regenerative potential4
Extracorporeal photopheresis in steroid-refractory chronic graft-versus-host disease: A retrospective multicenter study4
RHD 1227 A and hybrid Rhesus box analysis in Thai RhD+ and RhD- blood donors: Prevalence, RHD zygosity, and molecular screening4
Extracorporeal photopheresis in the treatment of acute and chronic graft-versus-host disease: A position statement from the Turkish Society of Apheresis (TSA)4
Can plasma exchange therapy be an option for the treatment of SARS-CoV-2 Related Splenial Lesion Syndrome: Two cases from the pediatric intensive care unit4
Evaluation of patients diagnosed with psoriasis and multiple myeloma after autologous stem cell transplantation4
Genotyping of blood groups in alloimmunized patients with β-thalassemia major by T-ARMS-PCR and multiplex-aso-pcr4
Impact of COVID-19 pandemic in the activity of a Therapeutic Apheresis unit in Italy4
Engraftment after autologous hematopoietic stem cell transplantation in patients mobilized with Plerixafor: A retrospective, multicenter study of a large series of patients4
The apheresis content analysis in Allo-HSCT represents reliable influential factors on graft-versus-host disease and overall survival4
Blood transfusion trends by disease category in the United States, 2000 to 20144
Identifying the possible causes of recurrent leukodepletion filter blockage in whole blood donations4
Perceptions and practices of the Brazilian LGBT+ population toward blood donation4
Factors influencing voluntary blood donation practice among university students of Bangladesh4
Defibrotide combined with triple therapy including posttransplant cyclophosphamide, low dose rabbit anti-t-lymphocyte globulin and cyclosporine is effective in prevention of graft versus host disease 4
Examining participant representation by sex, race, ethnicity and age in United States blood donation and blood transfusion clinical trials4
Hemolytic anemia and plasma exchange4
Idiopathic TTP in the Middle East: Epidemiology and clinical outcomes in infection associated episodes4
Predictors of poor haematopoietic stem cell mobilisation in patients with haematological malignancies at a South African centre4
Seroprevalence of SARS-CoV-2 IgG antibody among healthy blood donors: a single centre study4
The demographic and serological characteristics of COVID-19 convalescent plasma donors: Identification of basic criteria for optimal donor selection4
Platelet number and function alterations in preclinical models of sterile inflammation and sepsis patients: implications in the pathophysiology and treatment of inflammation4
Seroprevalence of SARS-CoV-2 antibodies in blood donors during the third wave of infection in Campeche Mexico4
Survey based cross-sectional study to analyse the variation of practices at blood centres during COVID-19 pandemic in India4
Transfusion support for patients with sickle cell disease4
Cyclophosphamide plus etoposide is a safe and effective mobilization regimen in patients with multiple myeloma3
Title: Effect of multiple maternal red cell alloantibodies on the occurrence and severity of Hemolytic Disease of the Fetus and Newborn3
Cold stored platelets – Increasing understanding and acceptance3
Low rates of anti-recipient isohemagglutinins in ABO incompatible hematopoietic stem cell transplants3
Polyclonal immunoglobulins for COVID-19 pre-exposure prophylaxis in immunocompromised patients3
Transfusion-associated babesiosis in China: A case report3
Selection of the mobilization regimen in lymphoma patients: A retrospective cohort study3
A patient affected by critical COVID-19 pneumonia, successfully treated with convalescent plasma3
Identifying correlations between donor demographics and isohemagglutinin titers as a potential method to screen for low-titer group O whole blood3
Prognostic Value Evaluation of HLA-DRB1*07:01, *10, *12, *13:01 Alleles for Alloimmunization in Transfusion-Dependent Thalassemia3
How is transfusion-associated graft-versus-host disease similar to, yet different from, organ transplantation-associated graft-versus-host disease?3
Whole blood derived covid convalescent plasma: An economical option among developing countries3
Plerixafor strategies for autologous hematopoietic cell transplant mobilization: A comparison of efficacy and cost3
Mathematics of apheresis3
Covid-19-induced coagulopathy and observed benefits with anticoagulation3
Efficacy and safety of plasmapheresis in symptomatic hyperviscosity and cast nephropathy: A Multicenter Experience in Turkey3
Mechanism of TLR4 mediated immune effect in transfusion-induced acute lung injury based on Slit2/Robo4 signaling pathway3
Comparison between intraoperative bleeding score and ROTEM® measurements to assess coagulopathy during major pediatric surgery3
Management of factor XI deficiency in oncological liver and colorectal surgery by therapeutic plasma exchange: A case report3
Urgent therapeutic plasma exchange3
Therapeutic plasma exchange for envenomation: Is it reasonable?3
The Italian registry of therapeutic apheresis enters the information system of transfusion services - SISTRA3
Hepcidin as a diagnostic marker of iron deficiency in blood donors3
Models to predict the probability for intraoperative RBC transfusion during lumbar spinal stenosis and femoral fracture surgeries in aged patients3
Plasmapheresis in ABO incompatible kidney transplant3
Reduced volume of red blood cell priming is safe for pediatric patients undergoing therapeutic plasma exchange3
Tailoring haemophilia A prophylaxis with BAY 81-8973: A case series3
The effect of a viscoelastic-guided bleeding algorithm implementation on blood products use in adult liver transplant patients. A propensity score-matched before-after study3
Lenograstim versus filgrastim in mobilization before autologous hematopoietic stem cell transplantation in patients with multiple myeloma and lymphoma - Single center experience3
Effects on mortality of early vs late administration of convalescent plasma in the treatment of Covid-193
Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation in adult patients: Diagnosis, incidence, prophylaxis, and treatment3
A pilot study on impact of use of medium molecular weight hydroxyethyl starch in granulocyte apheresis using Spectra Optia3
Therapeutic leukapheresis and thrombapheresis in medical emergencies3
Regenerative effect of expired platelet concentrates in human therapy: An update3
Global burden of transfusion in sickle cell disease3
Impact of HLA-G +3142C>G on the development of antibodies to blood group systems other than the Rh and Kell among sensitized patients with sickle cell disease3
Safety of peripheral blood stem cell harvest in children under anaesthesia in the day care setting – A single centre experience3
Impact of Covid 19 pandemic on hematopoietic stem cell transplantation activities: Report from a single center3
DMSO (Me2SO) concentrations of 1-2% in combination with pentaisomaltose are effective for cryopreservation of T cells3
Seroprevalence and trends of transfusion transmissible infections among retrospective blood donors in Western Azerbaijan Regional Blood Transfusion Center, Iran: A ten-years evaluation3
Overview on novel strategies and current guidelines for hematopoietic stem cell mobilisation and collection3
The world apheresis association registry, 2023 update3
Blood donors, iron deficiency and supplementation options – Will clinical trials help moving forward?3
First experience of the use of a generic of plerixafor in peripheral blood stem cell mobilization in multiple myeloma and lymphoma patients3
Pancytopenia in a newborn due to maternal piperacillin and human leukocyte antigen antibodies3
Human placenta-derived mesenchymal stromal cells transfusion in a critically Ill infant diagnosed with Coronavirus Disease 2019 (COVID-19): A case report3
Relative immunogenicity of blood group antigens: First report in a Korean population3
Therapeutic plasma exchange-free treatment for first-episode TTP: A systematic review3
Efficacy of convalescent plasma therapy in severe COVID-19 patients3
Deferral due to low hemoglobin and predictors of permanence in the blood donation system of repeat female blood donors3
Clinical and immunohematological characterization of autoimmune hemolytic anemia in children3
Artificial intelligence in transfusion medicine and its impact on the quality concept3
Process capability indexes: Trends and developments in the manufacturing of blood components3
Therapeutic plasma exchange in the management of acute complications of sickle cell disease: A single centre experience3
Establishment of a cell processing laboratory to support hematopoietic stem cell transplantation and chimeric antigen receptor (CAR)-T cell therapy3
A multicenter retrospective analysis on therapeutic plasma exchange in immune thrombocytopenic purpura3
0.040105104446411